BNP Paribas SA
F:BNP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BNP Paribas SA
F:BNP
|
FR |
|
C
|
Capri Holdings Ltd
F:MKO
|
UK |
|
C
|
Corcept Therapeutics Inc
XMUN:HTD
|
US |
|
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
KR |
|
Wal Mart de Mexico SAB de CV
F:4GNB
|
MX |
|
E
|
Eastman Chemical Co
XMUN:EAC
|
US |
|
D
|
DSV A/S
SWB:DS81
|
DK |
|
F
|
Fast Retailing Co Ltd
F:FR7
|
JP |
|
Relx PLC
LSE:REL
|
UK |
|
M
|
Moody's Corp
F:DUT
|
US |
|
A
|
Ally Financial Inc
LSE:0HD0
|
US |
|
C
|
Cisco Systems Inc
XMUN:CIS
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BNP's stock price target?
Price Target
118.8
EUR
According to Wall Street analysts, the average 1-year price target for
BNP is 118.8 EUR with a low forecast of 99.28 EUR and a high forecast of 141.78 EUR.
What is the Revenue forecast for BNP Paribas SA?
Projected CAGR
-11%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is -11%.
What is the Net Income forecast for BNP Paribas SA?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 4 years is 1%.